BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35489080)

  • 1. The Added Value of Crescents on Oxford Classification Score in Risk Stratification of End-stage Kidney Disease in Patients with IgA Nephropathy.
    Ossareh S; Nazemzadeh N; Asgari M; Bagherzadegan H; Afghahi H
    Iran J Kidney Dis; 2022 Mar; 16(2):115-124. PubMed ID: 35489080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Significance of Crescents on the Clinical Features and Outcomes of Primary Immunoglobin A Nephropathy.
    Du Y; Chen S; Wang F; Zhang P; Liu M; Liu C; Zhong X; Qin J; Li G; Wang W
    Front Med (Lausanne); 2022; 9():864667. PubMed ID: 35847826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
    Monteiro MLGDR; Vieira MR; Pereira LHM; Araújo LS; Silva CA; Araújo LB; Rocha LP; Reis MAD; Machado JR
    Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mixed-method evaluation of the relationship between Oxford classification scores and longitudinal changes in proteinuria in patients with immunoglobulin A nephropathy.
    Xu RC; Guo JY; Cao T; Xu Y; Liao Y; Chen YN; Song HY; Chen XJ; Guan MJ; Tang F; Xiang Q; Chen XL; Wan QJ
    Front Endocrinol (Lausanne); 2022; 13():890900. PubMed ID: 36704031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological Characteristics and Impacts on Clinical Outcomes of Thrombotic Microangiopathy Lesions in Patients with Immunoglobulin A Nephropathy in Thailand.
    Puapatanakul P; Banjongjit A; Kanjanabuch T; Surintrspanont J; Iampenkhae K; Praditpornsilpa K; Eiam-Ong S; Boonpucknavig V
    Am J Nephrol; 2023; 54(7-8):308-318. PubMed ID: 37429271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Outcomes in Brazilian Patients with Immunoglobulin A Nephropathy and Cellular Crescentic Lesions.
    Neves PDMM; Pinheiro RBB; Dias CB; Yu L; Testagrossa LA; Cavalcante LB; Malheiros DMAC; Jorge LB; Woronik V
    Kidney Blood Press Res; 2020; 45(3):431-441. PubMed ID: 32299081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
    Bagchi S; Singh G; Yadav R; Kalaivani M; Mahajan S; Bhowmik D; Dinda A; Agarwal SK
    Ren Fail; 2016; 38(3):431-6. PubMed ID: 26837482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
    Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
    Terinte-Balcan G; Stancu S; Zugravu A; Capusa C; Radu A; Mircescu G; Stefan G
    J Nephrol; 2023 Nov; 36(8):2233-2243. PubMed ID: 37632668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin A Deposits In Renal Allografts: A Prospective Longitudinal Single-Center Study.
    Ganesh K; Jayaram JK; Thomas RM; Abraham TT; Kumar JS; Simon SS; Abraham MA
    Transplant Proc; 2024; 56(1):97-104. PubMed ID: 38216361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients.
    Zeng CH; Le W; Ni Z; Zhang M; Miao L; Luo P; Wang R; Lv Z; Chen J; Tian J; Chen N; Pan X; Fu P; Hu Z; Wang L; Fan Q; Zheng H; Zhang D; Wang Y; Huo Y; Lin H; Chen S; Sun S; Wang Y; Liu Z; Liu D; Ma L; Pan T; Zhang A; Jiang X; Xing C; Sun B; Zhou Q; Tang W; Liu F; Liu Y; Liang S; Xu F; Huang Q; Shen H; Wang J; Shyr Y; Phillips S; Troyanov S; Fogo A; Liu ZH
    Am J Kidney Dis; 2012 Nov; 60(5):812-20. PubMed ID: 22819700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores).
    Schimpf JI; Klein T; Fitzner C; Eitner F; Porubsky S; Hilgers RD; Floege J; Groene HJ; Rauen T
    BMC Nephrol; 2018 Nov; 19(1):328. PubMed ID: 30453889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
    Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
    BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
    Xu K; Zhang L; Ding J; Wang S; Su B; Xiao H; Wang F; Zhong X; Li Y
    J Nephrol; 2018 Apr; 31(2):279-286. PubMed ID: 29185209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
    Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics, risk factors and renal outcome in IgA nephropathy with crescents.
    Ruan Y; Hong F; Wu J; Lin M; Wang C; Lian F; Cao F; Yang G; Huang L; Huang Q
    J Nephrol; 2022 May; 35(4):1113-1121. PubMed ID: 35290652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Modified Oxford Score in Recurrent IgA Nephropathy in North American Kidney Transplant Recipients: The Banff Recurrent Glomerulonephritis Working Group Report.
    Alachkar N; Delsante M; Greenberg RS; Koirala A; Alhamad T; Abdalla B; Anand M; Boonpheng B; Blosser C; Maggiore U; Bagnasco SM
    Transplantation; 2023 Sep; 107(9):2055-2063. PubMed ID: 37202854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.
    Lv J; Shi S; Xu D; Zhang H; Troyanov S; Cattran DC; Wang H
    Am J Kidney Dis; 2013 Nov; 62(5):891-9. PubMed ID: 23820066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology.
    Lin Z; Liu L; Zhang R; Lin X; Lu F; Bao K; Wang L; Lin Q; Mai J; Cao Y; Yang H; Liu X; Zou C
    Am J Nephrol; 2021; 52(6):507-518. PubMed ID: 34134110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.